Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil

Detalhes bibliográficos
Autor(a) principal: Abuzwaida, Abdulbasit R. N.
Data de Publicação: 1987
Outros Autores: Sidoni, Marli, Yoshida, Clara F. T., Schatzmayr, Hermann G.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/28522
Resumo: Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory.
id IMT-1_60c1c20efe4a7a0adcf1d72770640ddf
oai_identifier_str oai:revistas.usp.br:article/28522
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil Soroepidemiologia de Hepatite A e B em duas comunidades urbanas do Rio de Janeiro, Brasil SoroepidemiologyHBsAg anti-HBs anti-HAV Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory. Foi determinada a prevalência de marcadores de hepatite B em amostras representativas de duas comunidades, Niterói (397) e Nova Iguaçu (680), encontrando-se 9,1% (1,0% de HBsAg e 8,1% de anti-HBs) em Niterójl e 11% (1,7% de HBsAg e 9,3% de anti-HBs) em Nova Iguaçú. Por estudo comparativo em relação à idade, foi verificada maior prevalência de HBsAg no grupo etário de 21 a 50 anos. Em relação a anti-HBs, foi demonstrado um aumento gradual com a idade, alcançando 14,9% em Niterói e 29,1% em Nova Iguaçú nos grupos de indivíduos acima de 51 anos de idade. Em relação a Hepatite A, em 259 amostras de Niterói, foi encontrada a prevalência de 74,5% de anticorpos anti-HAV. Esta prevalência aumentou gradualmente, alcançando 90% a partir de 30 anos. Em 254 amostras de Nova Iguaçu, a prevalência foi de 90,5%. Estes valores já são alcançados em crianças a partir de 10 anos. Todos os testes foram feitos em sistema imunoenzimático padronizado em nosso laboratório. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo1987-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/28522Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 4 (1987); 219-223 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/28522/30375Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessAbuzwaida, Abdulbasit R. N.Sidoni, MarliYoshida, Clara F. T.Schatzmayr, Hermann G.2012-07-02T00:57:39Zoai:revistas.usp.br:article/28522Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:50:15.169816Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
Soroepidemiologia de Hepatite A e B em duas comunidades urbanas do Rio de Janeiro, Brasil
title Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
spellingShingle Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
Abuzwaida, Abdulbasit R. N.
Soroepidemiology
HBsAg anti-HBs anti-HAV
title_short Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
title_full Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
title_fullStr Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
title_full_unstemmed Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
title_sort Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
author Abuzwaida, Abdulbasit R. N.
author_facet Abuzwaida, Abdulbasit R. N.
Sidoni, Marli
Yoshida, Clara F. T.
Schatzmayr, Hermann G.
author_role author
author2 Sidoni, Marli
Yoshida, Clara F. T.
Schatzmayr, Hermann G.
author2_role author
author
author
dc.contributor.author.fl_str_mv Abuzwaida, Abdulbasit R. N.
Sidoni, Marli
Yoshida, Clara F. T.
Schatzmayr, Hermann G.
dc.subject.por.fl_str_mv Soroepidemiology
HBsAg anti-HBs anti-HAV
topic Soroepidemiology
HBsAg anti-HBs anti-HAV
description Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory.
publishDate 1987
dc.date.none.fl_str_mv 1987-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/28522
url https://www.revistas.usp.br/rimtsp/article/view/28522
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/28522/30375
dc.rights.driver.fl_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 4 (1987); 219-223
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 4 (1987); 219-223
Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 4 (1987); 219-223
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951637204598784